Sign in

CIK 0001590750

  • Large accelerated filer

Viridian Therapeutics, Inc.\DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471187261
Phone
+1 617-272-4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$348,194
in 1 filing

Net −$348,194. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Tousignant Jennifer −$348K Chief Legal Officer sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2020-11-13 Logos Global Master Fund LP 10% owner Purchase +126,667 $14.84 $1.9M 550,000
2020-11-09 Logos Global Master Fund LP 10% owner Purchase +250,000 $1.10 $274K 6,250,000
2020-11-09 Logos Global Master Fund LP 10% owner Purchase +100,000 $1.16 $116K 6,350,000

Page 1 of 1 · 3 trades